Find information on Industry Analysis Report

Archive for the ‘pharmaceuticals’ Category

Healthcare Cloud Computing (Clinical, EMR, SaaS, Private, Public, Hybrid) Market – Global Trends, Challenges, Opportunities & Forecasts (2012 – 2017)

Technologies in the healthcare IT industry are converging with time and are far outpacing the legacy systems used by hospitals and healthcare providers. Pronouncements by various countries such as American Recovery and Reinvestment Act of 2009 (ARRA) laid down by the U.S. government are encouraging businesses in the healthcare industry to utilize certain applications of electronic records. Recently, cloud technology has started replacing these legacy systems and offers easier and faster access to this data as defined by the way it is stored i.e. public, private or hybrid.

Cloud computing offers significant benefits to the healthcare sector; Doctor’s clinics, hospitals, and health clinics require quick access to computing and large storage facilities which are not provided in the traditional settings, moreover healthcare data needs to be shared across various settings and geographies which further burdens the healthcare provider and the patient causing significant delay in treatment and loss of time. Cloud caters to all these requirements thus providing the healthcare organizations an incredible opportunity to improve services to their customers, the patients, to share information more easily than ever before, and improve operational efficiency at the same time. The flip side of this advantage is that healthcare data has specific requirements such as security, confidentiality, availability to authorized users, traceability of access, reversibility of data, and long-term preservation. Hence, cloud vendors need to account for all these while conforming to regulations such as HIPAA and Meaningful use.

All the above factors bring the market for cloud computing to grow at a CAGR of 20.5% from 2010 to 2017 in healthcare. Although cloud computing offers significant advantages to HCOs and other stakeholders, it has set of restraints. Security of patient information, interoperability and compliance with government regulations are some of the factors which are slowing down this market.

Cloud technology has been adopted only in certain regions of the world, the majority share being held by the developed nations. The geographies studied include North America, Europe, Asia, and ROW. North America accounts for the lion’s share in the cloud computing market with U.S. being the largest contributor to this region.

The healthcare cloud computing market is a fragmented one with no player occupying a share more than 5%. A few players in this market are CareCloud (U.S.), Carestream Health, Inc. (U.S.), Merge Healthcare, Inc. (U.S.), GE Healthcare (U.K.), and Agfa Healthcare (Belgium).

Find More:

Healthcare Cloud Computing (Clinical, EMR, SaaS, Private, Public, Hybrid) Market – Global Trends, Challenges, Opportunities & Forecasts (2012 – 2017)

Advertisements

Gammagard Liquid – Alzheimer’s Disease

Gammagard Liquid Alzheimer’s disease market offers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2022). Pharmaceutical market report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData’s team of industry experts.

Scope

  1. Therapy area profile including patient population for the US and EU5 (six major markets)
  2. Market analysis and review of Gammagard Liquid including sales data
  3. Qualitative and quantitative assessment of market space
  4. Analysis of the industry trends, drivers and restraints shaping and defining the markets
  5. In-depth analysis of Gammagard Liquid including efficacy, safety, pricing, competition and other details which influence its sales potential
  6. Global sales forecast for 2014-2022 for Gammagard Liquid

Reasons to buy Gammagard Liquid market Reports:

  1. Understand and capitalize by identifying products that are most likely to ensure a robust return
  2. Stay ahead of competition by understanding the changing competitive landscape
  3. Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  4. Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
  5. Examine the historical sales performance of a drug in seven major market

Endoscopy Devices Market

Mindray Medical Instrument Market report provides key insights on the endoscopy devices market. The report contains an analysis on the inorganic growth strategies of Mindray Medical, potential growth opportunities for Mindray in rigid endoscope and surgical equipment market, and increased distribution capacity of Hangzhou Optcla as a result of the deal. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Features:

  1. Deal overview of the acquisition of Hangzhou Optcla by Mindray Medical.
  2. Strategic rationale behind the deal including analysis on the impact of the deal on both the companies.
  3. Company profiles of Mindray Medical and Hangzhou Optcla.

Why to buy this report?

  • Understand Mindray Medical’s inorganic growth strategy.
  • Understand the business strategy behind this deal by a medical device company to strengthen its current product portfolio and enter new product segments showing positive future growth trend.
  • Understand the increased market presence and distribution capacities enjoyed by the acquired company post-acquisition.

Marketing and Sales Behaviors and Strategies in the Pharmaceutical Industry

Marketing and Sales Behaviors and Strategies in the Pharmaceutical Industry – 2012-2013 : Survey Brief

  • Analysis of opinions drawn from leading pharmaceutical industry executives
  • The report identifies and analyzes the key marketing and sales strategies companies will be adopting to deal with market conditions in 2012-2013

This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes the changing marketing behaviour and strategies of the companies in the pharmaceutical industry. The report also identifies the most significant strategies that pharmaceutical industry suppliers plan to implement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.

Find More:

Marketing and Sales Behaviors and Strategies in the Pharmaceutical Industry 

Medical Devices Industry Strategies

Marketing and Sales Behaviors and Strategies in the Medical Devices Industry – 2012-2013 : Survey Brief

  •  Analysis of opinions drawn from leading medical devices industry executives
  •  The report identifies and analyzes the key marketing and sales strategies companies will be adopting to deal with market conditions in 2012-2013

This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading medical devices industry executives. It analyzes the changing marketing behaviour and strategies of the companies in the medical devices industry. The report also identifies the most significant strategies that medical devices industry suppliers plan to implement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.

Scope

  • The opinions and forward looking statements of 174 industry executives have been captured in our in-depth survey, of which 54% represent Director and C-level respondents.
  • The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.
  • The geographical scope of the research is global – drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
  • This report covers data and analysis on supplier expenditure, sales and marketing and industry developments.
  • The report provides insights into the marketing needs of medical devices industry suppliers and how they are looking to develop their marketing and sales strategies in the future.
  • The report examines current practices and provides future expectations for the industry over the next 12-24 months.

Find More:

Medical Devices Industry Strategies 

Bare Metal Stents Market

Global Bare Metal Stents Market 2011-2015

TechNavio’s analysts forecast the Global Bare Metal Stents market to reach US$1.86 billion by 2015. One of the key factors contributing to this market growth is the high prevalence of cardiovascular diseases. The Global Bare Metal Stents market has also been witnessing the trend of increasing demand for minimally invasive procedures. However, the presence of alternative coronary stents could pose a challenge to the growth of this market.

TechNavio’s report, the Global Bare Metal Stents Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Bare Metal Stents market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Abbott Laboratories, Medtronic Inc., Cordis Corp., and Boston Scientific Corp. Other vendors mentioned in the report: Microport Scientific Corp., Cook Medical, Biosensors International Ltd., B. Braun Melsungen AG.

Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?

Find More:

Bare Metal Stents Market

Ultrasound Systems

Ultrasound Systems: Global Market Outlook 2012-2022

Our latest pharma report – Ultrasound Systems: Global Market Outlook 2012-2022 – offers a comprehensive view of the global ultrasound scanners market. The report analyses recent trends in this market and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also reveals the market’s strengths and weaknesses, revealing areas that will experience growth and present new business opportunities. Visiongain analyses predict the global value of the ultrasound systems market in 2011 to be worth $4.2bn. Growth in this market will be driven by new technology and varied uses of the technology.

Ultrasound imaging is one of the fastest growing sectors of the diagnostic imaging market. Ultrasound is cyclic sound pressure with a frequency greater than the upper limit of human hearing. Ultrasound is thus not separated from normal sound based on differences in physical properties, only the fact that humans cannot hear it. The most well known application of ultrasound is its use in sonography to produce pictures of foetuses in the human womb. It is possible to use ultrasound for both diagnosis and treatment. The market has significant potential for growth with the increasing global burden of diseases, as well the varied applications of the technology.

Ultrasound Systems: Global Market Outlook 2012-2022 report forecasts the size and value of leading national/regional markets including the US, Europe, Japan, India and China. For each of these, visiongain identifies prevailing trends and strategies that will steer this diagnostic technology over the forecast period. The market will be driven by primarily by the emerging BRIC economies. China and India will see the most significant growth over the forecast period. In response to patient demand, hospitals and healthcare care providers around the world are upgrading their older equipment with state of the art systems. Growth in the more advanced high-end ultrasound scanners will significantly outpace the lower entry-level end of the market. Two alternative uses for ultrasound which will see significant growth over the forecast period are intravascular ultrasound (IVUS) and ultrasound for drug delivery.

Tag Cloud